# Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid

> **NCT00381433** · PHASE1 · COMPLETED · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 12 (—)

## Conditions studied

- Encephalitis

## Interventions

- **DRUG:** AVI-4065 Injection

## Key facts

- **NCT ID:** NCT00381433
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2006-10
- **Final completion:** 2009-06
- **Target enrollment:** 12 (—)
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381433, "Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00381433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*